A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women After Vaccination With 9vHPV (RIFT-HPV).
Conditions: Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III); Human Papillomavirus (HPV) Infections; High-risk HPV; HPV-16/ 18 Intervention: Biological: Nonavalent HPV vaccine (9vHPV/Gardasil-9™). Sponsors: Miquel Angel Pavon Ribas; Hospital del Mar; Catalan Institute of Health Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2022 Category: Research Source Type: clinical trials
The Immunogenicity and Safety of the Vaccination of Human Papillomavirus Vaccine and Measles-Mumps-Rubella Vaccine
Conditions: Human Papilloma Virus Infection Type 16; Human Papilloma Virus Infection Type 18; Measles; Rubella; Mumps Interventions: Biological: HPV+MMR（0d），HPV（6m）; Biological: HPV（0d），HPV（6m），MMR（7m）; Biological: MMR（0d），HPV（1m），HPV（7m） Sponsor: Zhejiang Provincial Center for Disease Control and Prevention Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2022 Category: Research Source Type: clinical trials
